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Toll-like receptors (TLRs) act as primary sensors of the
immune system by recognizing specific microbial motifs and
inducing proinflammatory genes that facilitate innate and
adaptive immunity. TLRs regulate gene expression by activating
transcription factors, such as NF-B and interferon-regulatory
factors. Dysregulation of these pathways can lead to inflamma-
tory diseases, and thus they are subject to stringent control by
negative regulators of innate immune signaling. Cactin (Cactus
interactor) was initially discovered as a novel interactor ofDro-
sophilaCactus, a regulator ofDrosophilaToll signaling.Wenow
describe the first functional characterization of the human
ortholog of Cactin (hCactin) and show that it acts as a negative
regulator of TLRs. Overexpression of hCactin suppresses TLR-
induced activation of NF-B and interferon-regulatory factor
transcription factors and induction of TLR-responsive genes,
whereas knockdown of endogenous hCactin augments TLR
induction of these responses. hCactin also interacts with IB-
like protein and targets other proteins that are encoded by genes
in theMHCClass III region of chromosome 6.We demonstrate
that hCactin localizes to the nucleus, and this nuclear localiza-
tion is critical for manifesting its inhibitory effects on TLR sig-
naling. This study thus defines hCactin as a novel negative reg-
ulator of TLR signaling and reveals its capacity to target MHC
Class III genes at the molecular and functional level.
Toll-like receptors (TLRs)2 are type I transmembrane pro-
teins that possess an N-terminal leucine-rich repeat domain
that recognizes pathogen-associated molecular patterns, a sin-
gle transmembrane domain, and a C-terminal intracellular sig-
naling domain (1–3). TheTLRC terminus is homologous to the
intracellular domain of the type I IL-1 receptor (IL-1R) and is
termed the Toll/IL-1R (TIR) domain (4). To date, 13 murine
and 10 human TLRs have been identified (5). The engagement
of TLRs by pathogen-associated molecular patterns promotes
dimerization of the receptors, followed by recruitment of TIR
domain-containing adaptors and the initiation of downstream
signal transduction cascades (6–8). MyD88 (myeloid differen-
tiation primary response protein 88) is the universal TIR
adapter protein recruited by all TLRs exceptTLR3, and thus the
signaling pathways activated by TLRs are classified into
MyD88-dependent andMyD88-independent pathways (9–12).
The binding ofMyD88 to TLRs recruits members of the IL-1R-
associated kinase family (13–15). The IL-1R-associated kinase-
MyD88 association triggers hyperphosphorylation of IL-1R-as-
sociated kinase, leading to its dissociation from MyD88 and
interaction with the downstream adaptor TRAF-6 (tumor
necrosis factor receptor-associated factor 6) (16). This results
in activation of TAK-1 (transforming growth factor--activat-
ing kinase 1), leading to stimulation of IBkinases (IKKs). IKK
and IKK phosphorylate members of the IB family (17),
resulting in their polyubiquitination and proteasome-depen-
dent degradation (18). Members of the canonical cytoplasmic
IB family include IB, IB, and IB, and they function to
retain Rel subunits of NF-B in their inactive form in the
cytosol. Following degradation of the IB proteins, NF-B is
released, leading to exposure of a nuclear localization signal and
translocation ofNF-B to the nucleus (19).Once in the nucleus,
NF-B binds to a consensus decameric B-responsive DNA
element and induces the up-regulation of a plethora of genes
encoding proinflammatory proteins and co-stimulatory mole-
cules (20). In addition to this MyD88-dependent pathway,
TLR4 can also employ another TIR adaptor, termed TIR
domain-containing adaptor inducing IFN- (TRIF), to trigger
activation of NF-B in a MyD88-independent pathway (21).
TLR3 is unique among members of the TLRs in that it exclu-
sively employsTRIF as its receptor proximal adaptor protein. In
addition to activation of NF-B, TRIF can also form a complex
with TBK1 (TRAF family member-associated NF-B activator
(TANK)-binding kinase) and IKKi, which induce specific phos-
phorylation and activation of the transcription factors IRF3
(interferon-regulatory factor 3) and IRF7 to induce type I inter-
ferons (IFNs) (22).
A striking similarity of insect and vertebrate immunity lies in
the conserved role of Toll and TLRs in driving activation of the
Rel/NF-B transcription factor family in response to a per-
ceived pathogenic challenge. Thus, activation of NF-B and
the subsequent induction of immune response genes is a core
defensive mechanism of both fly and mammalian innate
immune responses. Moreover, NF-B fills dual roles in early
development and adult immunity in both insects and mam-
mals. In addition, consideration of the pathways leading to the
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activation of NF-B factor reveals homology at the level of the
intracellular signaling components utilized. Given such conser-
vation, the identification of novel proteins in the NF-B path-
way in the fly has proved valuable in adding to our understand-
ing of themolecular components of theNF-B signaling system
in mammalian cells. In 2000, Cactus, the Drosophila ortholog
of IB, was employed as bait in a yeast two-hybrid screen,
leading to identification of a novel Cactus-interacting protein
termed Cactin (23).Drosophila Cactin was shown to be mater-
nally inherited, and its overexpression promoted a ventralized
phenotype in the early Drosophila embryo. Given that the
NF-B family member Dorsal is subject to inhibition by Cactus
and that Dorsal is an important trigger of ventralization, these
studies suggested that Cactin positively regulates Dorsal func-
tion in earlyDrosophila development.More recent studies have
confirmed early developmental roles forCactin in zebrafish and
Caenorhabditis elegans (24, 25). However, there are no existing
data on its function in higher organisms. In addition, an
immune function for Cactin has not yet been investigated. The
parallels between the fly and human TLR pathways at the
molecular level prompted us to perform the first functional
characterization of the human ortholog of Cactin (hCactin).
Given that IB, the mammalian ortholog of Cactus, is cen-
tral in control of NF-B activation and regulation of inflamma-
tory signaling, we were especially interested in exploring the
potential of human Cactin to act as a novel regulator of innate
immune signaling. We thus cloned hCactin and demonstrated
it to be a negative regulator of TLR signaling. Intriguingly,
hCactin fails to interact with the cytoplasmic IB proteins but
instead localizes to the nucleus of the cell, where it interacts
with IB-like (IBL) protein and some other proteins that are
encoded by genes in the MHC Class III region of chromosome
6. The strong association of the genes in this genomic region
with inflammatory diseases coupled to the inhibitory effects of
hCactin on innate immune signaling promotes hCactin as a
highly novel and crucially important regulator of immunity-
mediated disease.
EXPERIMENTAL PROCEDURES
Biological Reagents and Cell Culture—The anti-IRF3 anti-
body was from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA). Monoclonal anti-Myc and anti-phospho-IRF3 antibodies
were fromCell Signaling Technology Inc. (Danvers,MA). Anti-
-actin antibody was supplied by Sigma-Aldrich. The plasmids
pCMV-dR 8.91 and VSV-G and constructs encoding IRF3/7
Gal4 reporter and IFN--luciferase reporter were gifts fromDr.
Kate Fitzgerald (University of Massachusetts Medical School,
Worcester, MA). The pFR-luciferase Gal4 reporter construct
was a gift from Prof. Andrew Bowie (Trinity College, Dublin,
Ireland). The NF-B-luciferase reporter construct was a gift
from Prof. Luke O’Neill (Trinity College). GFP-tagged IB-L
was a present from Dr. Ross McManus (Trinity College). The
human embryonic kidney 293 (HEK293) cells that stably
express TLR3 and TLR4 receptors were from InvivoGen (San
Diego, CA), and U373 cells were a gift from Dr. Sinead Miggin
(National University of Ireland, Maynooth, Ireland). THP-1
suspension cells were a gift from Prof. Catherine Godson (Con-
way Institute, University College Dublin).
HEK andU373 cells weremaintained inDulbecco’smodified
Eagle’s medium (DMEM), which was supplemented with 10%
(v/v) fetal bovine serum (FBS), 100 units/ml penicillin, and 100
g/ml streptomycin. G418 (500 g/ml) was used to select for
the stably transfected TLR cell lines. THP-1 suspension cells
were grown in Roswell Park Memorial Institute (RPMI)
medium supplemented with 2 mM L-glutamine, 10% (v/v) FBS,
and penicillin/streptomycin (100 units/ml and 100 g/ml,
respectively). Cells were maintained in a 37 °C humidified
atmosphere with 5% CO2.
Cloning and Expression Vectors—hCactin (nucleotides
40–2330 of GenBankTM entry NP_067054) was initially TOPO-
cloned (TOPO TA cloning kit, Invitrogen) from 1321N1 astro-
cytoma, and this was used as a template for PCR amplification,
with the PCR product being ligated into pcDNA3.1/Zeo
(Invitrogen), pEGFP-N1, and pIRES2-DsRed (BD Biosciences)
mammalian expression vectors. The primers 5-GATCGAAT-
TCCACTGGCCCAGCCGATGGGTC-3 and 5-TACTCTT-
CACTTGGCCTCCTTCTTGGCCAGCC-3 were used in the
PCR for subsequent ligation with pcDNA3.1 cloning (with the
c-Myc epitope tag at the C terminus); primers 5-GATCCTC-
GAGGCCACCATGGGTCGGGACACACGCTCGC-3 and 5-
GATCGAATTCCCCGCCGATAGCGGTAGCGCTT-3 were
used for cloning into pEGFP-N1. PCR products and vectors
were double-digested with 30 units each of EcoRI and XhoI at
37 °C overnight and thenmixed in ligation reactions. The integ-
rity of all generated clones was confirmed by sequencing. The
truncation mutant of hCactin was generated by PCR using the
GC-RICH PCR system (Roche Applied Science) and TOPO
cloned DNA template with the forward primer 5-ATCC-
TCGAGGATGAACCAGCTGCAGGTCAT-3 and reverse
primer 5-ATCGGATCCGCCGCCGATAGCGGTAGCG-
CTT-3. These primers contain restriction sites for XhoI and
BamHI, respectively. The PCR products were cloned into the
pcDNA3.1/Zeo and pEGFP-N1 mammalian expression vec-
tors as described above.
Lentiviral Production and Transduction—HEK293 T cells
were seeded (2 105 cells/ml; 3 ml) in 6-well plates and grown
for 24 h to 80% confluence. The cells were transfected using
Lipofectamine 2000 (Invitrogen) according to the manufactur-
er’s instructions with the packaging plasmid pCMV-dR 8.91
(900 ng), envelop plasmidVSV-G (100ng), sh-pLKO.1 vector (1
g), and hCactin shRNA or control shRNA (Sigma-Aldrich):
hCactin shRNA1, 5-CAGGGATACAAGTTCAACATC-3;
hCactin shRNA2, 5-AGGTCAGATTCAGAGGAAGAG-3.
The control shRNA (CT) is a non-targeting shRNA vector that
encodes for shRNA that does not match to any known human
or mouse gene. The conditioned medium was changed 24 h
post-transfection and replaced with fresh growthmedium con-
taining 30% (v/v) FBS. The cells were then incubated for a fur-
ther 24 h. The lentivirus-containingmediumwas harvested and
stored at 20 °C. Fresh growth medium containing 30% (v/v)
FBS was again added to cells and incubated for another 24 h.
The virus-containing medium was again harvested and stored
for use.
THP-1 andU373 cells were seeded (2 105 cells/ml; 3ml) in
6-well plates and grown for 24 h. The growthmediumwas then
removed and replaced with fresh medium containing Poly-
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brene (8 g/ml) and 600 l of lentivirus-containing medium
from above. The plates were incubated at 37 °C for 24 h, after
which the medium was removed and replaced with fresh
growth medium containing puromycin (5 g/ml) to select for
cells transduced with shRNA. Prior to experiments, cells were
selected for another 2–3 weeks in the presence of puromycin.
Transfection and Luciferase Reporter Systems—HEK293
cells, stably expressing TLR3 or TLR4, were seeded (1.5  105
cells/ml; 200l) in 96-well plates and grown for 24 h. Cells were
then transfected, using Lipofectamine 2000 (Invitrogen), with
NF-B firefly luciferase reporter construct (80 ng) or IFN-
promoter-regulated firefly luciferase (80 ng), constitutively
expressed TK Renilla luciferase reporter construct (phRL-TK,
20 ng; Promega), and varying amounts of expression con-
structs. In some experiments, transfections also included
siRNAs (25 nM) (Invitrogen) targeting hCactin (sense sequence,
5-UCUUGAAGUGCUCUGCCUCCUUCUC-3) and a corre-
sponding scrambled siRNA (sense sequence, 5-GAGAAGGA-
GGCAGAGCACUUCAAGA-3). In all transfections, total
DNA was kept constant (310 ng/well) using the appropriate
empty vector. The activation of IRF3, IRF7, and c-Jun was
determined by performing similar transfections using Gal4-
firefly luciferase reporter plasmid pFR-Luc (60 ng) with the
trans-activator plasmids pFA-IRF3, pFA-IRF7, or pFA-Jun
(activation domain of IRF3, IRF7, or Jun is fused with the yeast
Gal4 DNA binding domain) (30 ng), phRL-TK plasmid (20 ng),
and varying amounts of expression constructs. Cell extracts
were generated 24 h post-transfection using the reporter lysis
buffer (Promega), and extracts were assayed for firefly lucifer-
ase and Renilla luciferase activity using the luciferase assay sys-
tem (Promega) and coelenterazine (0.1 g/ml Insight Biotech-
nology Ltd.), respectively. Luminescence was monitored with a
Glomax microplate luminometer (Promega).
Cytokine Immunoassays—Conditioned medium from cells
was assayed for levels of IL-8, TNF, and RANTES by sandwich
ELISA (DuoSet kits (R&D Systems)) and for IFN using a
Singleplex kit (Meso Scale Discovery). All kits were used
according to the manufacturers’ instructions.
Co-immunoprecipitation Analysis—Cells were seeded (2 
105 cells/ml; 3 ml) in 6-well plates and transfected, using
Lipofectamine 2000, with defined amounts of various
expression constructs and/or siRNAs as described above.
Cells were washed with prechilled PBS (1 ml) and then lysed
with prechilled lysis buffer (0.5 ml) (50 mM Tris-HCl, pH 7.5,
containing 150 mM NaCl, 0.5% (v/v) IGEPAL, 50 mM NaF, 1
mM Na3VO4, 1 mM dithiothreitol (DTT), 1 mM phenylmeth-
ylsulfonyl fluoride (PMSF), and protease inhibitor mixture
(leupeptin (25 g/ml), aprotinin (25 g/ml), benzamidine (1
mM), trypsin inhibitor (10 g/ml)) for 30 min on a rocker at
4 °C. Lysates were centrifuged at 12,000  g for 10 min at
4 °C. Supernatants were removed to new tubes, and protein
concentrations were determined by the method of Bradford
(26). Aliquots (50 l) were retained for Western immuno-
blotting, whereas the remaining supernatant was incubated
with mixing for 30 min at 4 °C with rabbit IgG (1 g) and
Protein A/G-agarose beads (10 l). Samples were centri-
fuged at 1000  g for 5 min at 4 °C to pellet non-specifically
bound proteins. Supernatants were removed to fresh pre-
chilled tubes. Samples were incubated overnight with anti-
Myc antibody (2 g) at 4 °C with rocking. This was followed
by the addition of protein A/G-agarose beads (20 l/sam-
ple). Incubations were placed at 4 °C with rocking for 4 h.
Immunoprecipitates were collected by centrifugation at
1000  g for 5 min at 4 °C, and the beads were then washed
four times with lysis buffer (500 l) lacking the protease
inhibitor mixture. The beads were then resuspended in 2
SDS-PAGE sample buffer (40 l) and incubated for 30 min at
room temperature. Samples were centrifuged at 16,000  g
for 2 min, subsequently boiled at 100 °C for 5 min, and sub-
jected to Western immunoblotting as described previously
(27). Nitrocellulose blots were blocked for 1 h in 20 mM
Tris-HCl, pH 7.5, containing 0.05% (v/v) Tween 20 and 0.5 M
NaCl (TBS) and 5% (w/v) skimmed milk powder. Blots were
incubated overnight at 4 °C with primary antibodies (at rec-
ommended concentrations) in blocking buffer followed by a
1-h incubation with IRDye secondary antibodies (Licor Bio-
sciences) (1:5000 dilution in blocking buffer). The immuno-
reactive bands were detected, and images were captured
using the Odyssey infrared imaging system from Licor
Bioscience.
Electrophoretic Mobility Shift Assay (EMSA)—THP-1 and
U373 cells, stably transduced with control shRNA or Cactin-
specific shRNAs, were grown in 6-well plates for 24 h. Cells
were then stimulated with LPS or poly(I-C) for various times.
Nuclear extracts were generated as described previously
(28). Nuclear protein (10 g) was incubated with LiCor IRDye
700-labeled oligonucleotide containing the NF-B binding
site 5-AGTTGAGGGGACTTTCCCAGGC-3 (B site under-
lined) according to the manufacturer’s instructions. For super-
shift analysis, polyclonal antibody (1 g) against the NF-B
subunit p65 or C-Rel or nonimmune IgG was added to the
extracts and chilled for 30 min in ice prior to incubation with
labeled oligonucleotide. All incubations were subjected to elec-
trophoresis on a 4% native polyacrylamide gel for 2 h at 110 V
and subsequently analyzed and images captured using the
Odyssey infrared imaging system.
Quantitative Real-time PCR—Cells were seeded (2  105
cells/ml; 3 ml) into 6-well plates and grown for 24 h. After
transfection, cells were treated with poly(I-C) (25 g/ml) for
various time periods. Cells were washed in PBS, and RNA
was extracted using Tri-Reagent (Sigma). After DNase I
digestion, cDNA was generated from normalized RNA using
avian myeloblastosis virus reverse transcriptase (Promega).
Samples were assayed by quantitative real-time PCR for lev-
els of IFN- or hCactin cDNA using Brilliant SYBR Green
QPCR Master Mix (Stratagene). PCR was conducted with
the CFB-322001G Opticon thermal cycler (Bio-Rad). Reac-
tions were performed using prevalidated primers (Eurofins
MWG Operon): forward hCactin, 5-TACACCAACACCG-
ACAACCC-3; reverse hCactin, 5-TTCAGCTCCTTCTC-
CTCCAG-3; forward IFN-, 5-GACCAACAAGTGTCT-
CCTCCAAA-3; reverse IFN-, 5-CTCCTCAGGGATGT-
CAAAGTTCA-3; forward HRPT, 5-GGTGAAAAGGAC-
CCCACGAA-3; reverse HPRT, 5-GGCGATGTCAA-
TAGGACTCCAGAT-3.
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Screening of Tissue Distribution of hCactin—RNA was ex-
tracted from various murine tissues using TRIzol according
to the manufacturer’s instructions (Sigma). cDNA was
generated as above and used as template for PCR using prim-
ers for hCactin and GAPDH: hCactin primers as above;
forward GAPDH, 5-CCATGCCATCACTGCCACCCA-
GAA-3; reverse GAPDH, 5-GTCCACACCCTGTTGCTG-
TAGCCG-3. PCR fragments were analyzed by agarose gel
electrophoresis.
Confocal Microscopy—HEK293 TLR4 cells were seeded (2
105 cells/ml) in 4-well chamber slides (Lab-Tek, Nunc A/S,
Roskilde, Denmark) and grown for 24 h to 80% confluence.
Cells were transfected using Lipofectamine 2000 with plasmids
encoding truncated hCactin-pEGFP or hCactin-pRFP and
IBL-pEGFP (400 ng). Processing of samples was performed on
ice. Medium was removed, and the cells were gently washed
three times in chilled 1 PBS (500 l). Cells were then fixed by
the addition of 2% (v/v) paraformaldehyde (500 l) for 20 min.
Cells were washed three times with PBS. An aliquot (500 l)
of 4,6-diamidino-2-phenylindole
(DAPI) (1.5 g/ml) in water was
added to each well for 1 min. Cells
were mounted with Vectashield
hard set mountingmedium (Molec-
ular Probes, Inc.). Confocal images
were captured using the 40 or
63 objective lens on the Olympus
FluoView FV1000 confocal laser-
scanning microscope or UV Zeiss
510 Meta System laser-scanning
microscope equipped with the
appropriate filter sets. Acquired
images were analyzed using the
Olympus FV-10 ASW imaging soft-
ware or LSM 5 browser imaging
software, respectively.
Statistical Analysis—Data are ex-
pressed relative to untreated cells
transfected with empty vector and
are the means  S.E. of triplicate
determinations from three inde-
pendent experiments. For compari-
son between two groups, paired Stu-
dent’s t test (one tail) was used. A
p value of 0.05 was considered
significant.
RESULTS
hCactin Is Widely Expressed and
Acts as a Negative Regulator of the
NF-B Pathway—hCactin was ini-
tially assessed for its tissue distri-
bution using RT-PCR to measure
mRNA levels in various murine
tissues. hCactin is ubiquitously
expressed with detectable expres-
sion in samples from various parts
of the brain and a wide variety of
peripheral organs (Fig. 1A). Given thatCactinwas discovered in
Drosophila as a Cactus-interacting protein and Cactus is a
homologue of the IB family that regulatesNF-B (23), hCactin
was initially probed for regulatory effects on NF-B signaling.
In order to perform this analysis,HEK293 cellswere transfected
with an expression plasmid encoding Myc-tagged hCactin and
assessed for its ability to induce the expression of a cotrans-
fected NF-B-regulated luciferase gene. Overexpression of
hCactin failed to activate NF-B (Fig. 1B). hCactin was next
examined for regulatory effects on inflammatory signaling
pathways known to activate NF-B. These studies demon-
strated that overexpression of hCactin inhibits the activation of
NF-B in response to endogenous proinflammatory stimuli,
such as IL-1 and TNF- (Fig. 1B), and exogenous ligands for
TLR2, TLR3, and TLR4, namely PamCys, poly(I-C), and LPS,
respectively (Fig. 1C). The functional consequences of such
hCactin-mediated down-regulation of NF-B was confirmed
by showing that overexpression of hCactin reduced the ability
of these proinflammatory stimuli to induce expression of the
FIGURE 1. hCactin is ubiquitously expressed and inhibits IL-1, TNF-, PamCys, poly(I-C), and LPS-in-
duced activation of NF-B. A, tissue distribution of Cactin. Total RNA was extracted from various tissues and
subjected to RT-PCR using Cactin- andGAPDH-specific primers. B–E, HEK293 cells stably transfectedwith TLR2,
TLR3, and TLR4 were cotransfected with plasmids encoding NF-B-regulated firefly luciferase (80 ng) and
constitutively expressed TK Renilla luciferase (40 ng) in the absence or presence of Cactin (90 ng). Empty vector
(EV) pcDNA3.1 was used to normalize the amount of total DNA transfected. Transfected cells were left over-
night and then treated with or without various ligands: IL-1 (10 ng/ml) and TNF- (50 ng/ml) (B and D) or
PamCys (100 ng/ml), Poly(I-C) (25 g/ml), and LPS (100 ng/ml) (C and E) for 6 h. Cell lysates were assayed for
firefly luciferase activity and normalized for transfection efficiency using Renilla luciferase activity (B and C).
Data are represented relative to untreated cells that had been transfected in the absence of hCactin. Condi-
tioned media from cells were also assayed for IL-8 levels by sandwich ELISA with data being expressed in
absolute concentrations of IL-8 (D and E). Data are presented as the mean  S.E. (error bars) of triplicate
determinations from three independent experiments and analyzed by paired Student’s t test. *, p 0.05; **,
p 0.01; ligand-stimulated cells transfected with empty vector versus ligand stimulated cells transfected with
hCactin.
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NF-B-responsive gene IL-8 (Fig. 1, D and E). The inhibitory
effects of hCactin were not due to nonspecific cytotoxicity
because the overexpression of hCactin had no effect on cell
viability (data not shown).
In order to further confirm the inhibitory effects of hCactin
on NF-B, the overexpression studies were complemented by
use of hCactin-specific siRNAs to suppress endogenous expres-
sion of hCactin. The efficacy and specificity of the hCactin
siRNA was initially proved by showing that transfection of
HEK293 cells, stably expressing TLR4, with hCactin siRNA
suppressed hCactin expression at themRNA (Fig. 2A) and pro-
tein (Fig. 2B) levels, whereas a sequence-scrambled version of
this siRNA failed to affect expression. These validated siRNAs
were then examined for their regulatory effects on the various
proinflammatory stimuli and their capacity to activate NF-B
as assessed by induction of the NF-B-regulated luciferase
gene. HEK293-TLR4 cells (or HEK293-TLR3 cells in the case of
poly(I-C)) were cotransfected with the NF-B luciferase
reporter gene with or without
hCactin-specific siRNA or scram-
bled siRNA. Cells were then treated
with a variety of stimuli, including
IL-1, TNF-, LPS, or poly(I-C).
The transfection of cells with
scrambled siRNA failed to affect the
activation ofNF-Bby these various
ligands. However, hCactin-specific
siRNA augmented the activation of
NF-B in response to each of the
proinflammatory stimuli (Fig. 2C),
thus complementing the overex-
pression studies and further con-
firming the inhibitory regulatory
effects of hCactin on the NF-B sig-
naling pathway.
Given that the above studies were
performed in HEK293 cells that
were engineered to express some of
the TLRs, it was next important to
demonstrate a functional role for
hCactin in a more physiologically
relevant system that was naturally
responsive to these various proin-
flammatory stimuli. We were also
keen to assess the cell type specific-
ity of hCactin function, and we thus
examined its role in two different
cell types that naturally express
TLRs. THP-1 is a human, acute
monocytic, leukemia cell line that
naturally expresses TLR4 and
responds to LPS (29), whereas
the U373 human astrocytoma cell
responds to the TLR3 ligand
poly(I-C) (30). Because these cells
are relatively refractory to trans-
fection, we transduced them with
lentiviral particles containing a
plasmid encoding hCactin-specific shRNA. Given that this
construct also encodes a puromycin resistance gene, the
approach also offered the considerable advantage of select-
ing populations of cells exhibiting stable integration of the
construct and thus stable knockdown of hCactin expression.
Quantitative RT-PCR was used to confirm hCactin knock-
down in cells transduced with hCactin shRNA versus cells
that had been transduced with control shRNA that did not
target hCactin (Fig. 3A). Both populations of THP-1 cells
that had been transduced with control or hCactin shRNA
were stimulated with LPS and assessed for induction IL-8.
Although hCactin shRNA had no effect on basal expression
of IL-8, it strongly augmented the efficacy of LPS in inducing
IL-8 (Fig. 3B). The potentiation of LPS signaling by hCactin
knockdown is not restricted to monocytic cells and is not
specific for expression of IL-8 because U373 cells that were
transduced with hCactin shRNA similarly demonstrated
enhanced LPS-induced expression of TNF (Fig. 3C). Such
FIGURE2.KnockdownofhCactinby siRNAaugments IL-1, TNF-, LPS, andpoly(I-C)-inducedactivation
ofNF-B.A, HEK293 cells, stably expressing TLR4, were transfectedwith hCactin-specific siRNAor a sequence-
scrambled versionof this siRNA (25nM). Total RNAwas extracted 48hpost-transfection. The expression level of
hCactinwas normalized relative to expression of the housekeeping geneHPRT. Data represent themean from
three independent experiments. B, HEK293 TLR4 cells were transfected withMyc-tagged Cactin (2g) with or
without Cactin siRNA or scrambled siRNA (10 nM). Cell lysates were generated 48 h post-transfection and
analyzed by Western immunoblotting (IB) using anti-Myc and anti--actin antibodies. Results are representa-
tive of two independent experiments. C, HEK293-TLR4 or -TLR3 (in the case of poly(I-C)) cells were cotrans-
fected with plasmids encoding NF-B-regulated firefly luciferase (80 ng) and constitutively expressed TK
Renilla luciferase (40 ng) in the absence (Mock) or presence of Cactin-specific siRNAor scrambled siRNA (25nM).
48 h post-transfection cells were treated with or without various ligands: IL-1 (10 ng/ml), TNF- (50 ng/ml),
LPS (100 ng/ml), or poly(I-C) (25 g/ml) for 6 h. Cell lysates were assayed for firefly luciferase activity and
normalized for transfection efficiency using Renilla luciferase activity. Data are presented relative to unstimu-
latedmock transfected cells and represent themean S.E. (error bars) of triplicate determinations from three
independent experiments and analyzed by paired Student’s t test *, p 0.05; **, p 0.01; ligand-stimulated
cells transfected with scrambled siRNA versus ligand-stimulated cells transfected with hCactin-specific siRNA.
Cactin Targets MHC Class III Protein and Immune Signaling
36808 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285•NUMBER 47•NOVEMBER 19, 2010
 at M
aynooth U









augmentation of IL-8 and TNF expression is probably due to
potentiation of LPS-induced activation of NF-B because
THP-1 cells transduced with hCactin shRNA displayed ear-
lier, stronger, and more prolonged activation of NF-B in
response to LPS, as judged by an electrophoretic mobility
shift assay (Fig. 3D), relative to cells transduced by control
shRNA. The NF-B-DNA complexes contain the strongly
transactivating Rel subunits p65 and c-Rel, as evidenced by
supershift analysis using antibodies that specifically recog-
nize these subunits. Again the augmentation of NF-B acti-
vation in response to LPS was not limited to THP-1 cells and
was not specific for TLR4 because U373 cells that were trans-
duced with hCactin shRNA similarly demonstrated greatly
enhanced and more prolonged activation of NF-B in
response to the TLR3 ligand poly(I-C) relative to cells trans-
duced with control shRNA (Fig. 3E).
hCactin Inhibits the IRF Pathways and Induction of IRF-re-
sponsive Genes—The inhibitory effects of hCactin on IL-1, LPS,
and poly(I-C)-induced activation of NF-B and induction of
NF-B-responsive genes implicate hCactin as a negative regu-
lator of bothMyD88-dependent andMyD88-independent acti-
vation of NF-B. However, the MyD88-independent pathway
also triggers activation of the IRF transcription factors and
induction of type I interferons. It was thus of interest to probe
the potential of hCactin to regulate activation of the IRF path-
way. Because activation of the IRF pathway initially requires
phosphorylation of IRFs, followed by their dimerization and
nuclear translocation, hCactin was first assessed for its regula-
tory effects on phosphorylation of IRFs. In HEK293 cells
expressing TLR3, poly(I-C) induced time-dependent phosphor-
ylation of IRF as judged by immunoblotting using phospho-
IRF3-specific antibodies (Fig. 4A). The knockdown of hCactin
FIGURE 3.Cactin-specific shRNAaugments TLR activation of NF-B and induction of IL-8 in THP-1 andU373 cells. A, total RNAwas extracted fromTHP-1
cells, grown under puromycin selection, after transduction with hCactin shRNA1 or control shRNA. Samples were assayed by quantitative real-time PCR for
levels of hCactinmRNA and normalized relative to the housekeeping gene HPRT. Data represent themean from three independent experiments. Puromycin-
selected THP-1 (B) and U373 (C) cells, previously transduced with control or hCactin shRNA, were seeded into 96-well plates and stimulated with LPS (100
ng/ml) for 24 h. Supernatants were analyzed for IL-8 (B) and TNF production (C) using sandwich ELISA. Data are presented as the mean S.E. (error bars) of
triplicate determinations from three independent experiments and analyzed by paired Student’s t test. **, p 0.01; LPS-treated cells transduced with control
shRNA versus LPS-treated cells transduced with Cactin-specific shRNA. THP-1 (D) and U373 (E) cells stably transduced with Control or Cactin-specific shRNA
were grown in 6-well plates for 24 h. (Quantitative real-time PCR confirmed50% suppression of hCactin expression in U373 cells by Cactin-specific shRNA2.)
Cellswere then stimulatedwith LPS (100ng/ml) (D) or poly(I-C) (25g/ml) (E) for the indicated timeperiods. Nuclear extracts (10gof protein)were generated
and assayed for binding to an oligonucleotide containing a consensus NF-B-bindingmotif by EMSA. Nuclear extracts from cells stimulated for 1 hwith LPS or
poly(I-C) were preincubated with anti-p65 and c-Rel or nonimmune (IgG) antibody before assaying NF-B-DNA binding activity. These results are each
representative of two independent experiments.
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by specific siRNA caused stronger and more prolonged phos-
phorylation of IRF3 in response to poly(I-C) without affecting
the overall levels of IRF3. Interestingly, the levels of basal phos-
phorylated IRF3 were also slightly higher in the hCactin knock-
down cells. These data implicate an important inhibitory role
for hCactin in TLR-induced phosphorylation of IRF3. This is
further confirmed by studies showing that overexpression of
hCactin inhibits Poly(I-C)-induced expression of an IRF3
reporter gene (Fig. 4B). The inhibitory effect of hCactin on
TLR3 activation of IRFs also extends to regulation of IRF7
because activation of the latter is strongly inhibited by hCactin
(Fig. 4C). The regulatory effects of hCactin on TLR3 activation
of IRFs have important functional consequences for down-
stream gene expression as judged by the inhibitory effects of
hCactin on TLR3 activation of the IFN promoter (Fig. 4D).
Furthermore, knockdown of hCactin by siRNA in HEK-TLR3
cells augmented the induction of IFN mRNA in response to
poly(I-C) (Fig. 4E). The negative regulatory effects of hCactin
on the IRF/IFN pathways are also relevant to cells that natu-
rally express TLR3. Thus, U373 cells, transduced with hCactin
shRNA, show greatly enhanced induction of IFN protein in
response to poly(I-C) relative to cells transduced with control
shRNA (Fig. 4F). Furthermore, hCactin knockdown cells also
demonstrate augmented induction of another IRF-responsive
gene, RANTES, in response to poly(I-C) (Fig. 4G), indicating
that the negative effects of hCactin on IRFs have functional
consequences for downstream expression of multiple IRF-re-
sponsive genes. In addition, the regulation of the IRF pathways
by hCactin is not restricted to the TLR3 system because over-
expression of hCactin strongly inhibits LPS-induced activation
of IRF3 (Fig. 4H) and IRF7 (Fig. 4I), and conversely, knock-
down of endogenous expression of hCactin potentiates the acti-
vation of IRF3 (Fig. 4J) and IRF7 (Fig. 4K) in response to LPS.
Given the inhibitory effects of hCactin onmultiple transcrip-
tion factors, including NF-B, IRF3, and IRF7, it was important
to exclude the possibility that these effects are nonspecific in
nature and represent suppression of both global transcription
factor activation and general gene expression. This scenario
does not apply because we have also observed that overexpres-
sion of hCactin enhances the activation of the transcription
factor c-Jun by its upstream regulator MEKK1 (Fig. 5A),
whereas siRNA-mediated knockdown of endogenous expres-
sion of hCactin inhibitsMEKK1-driven activation of c-Jun (Fig.
5B). This indicates specificity of action for hCactin in that it
exerts differential effects on different transcription factor
pathways.
hCactin Fails to Interact with Canonical Cytoplasmic IB
Proteins but Interacts with Nuclear IBL—We next attempted
to address the mechanistic basis to the above described
FIGURE 4. hCactin negatively regulates TLR-mediated activation of IRF3 and IRF7 and induction of IRF-responsive genes. A, HEK293-TLR3 cells were
cotransfected with Cactin-specific siRNA or a sequence-scrambled siRNA (25 nM) and IRF3 (2 g) and grown for 48 h. Cells were stimulated with poly(I-C) (25
g/ml) for the indicated time periods, and cell lysates were generated and subjected toWestern blotting using anti-phospho-IRF3, anti-IRF3, and anti--actin
antibodies. Immunoreactivity was visualized using the Odyssey infrared imaging system. Results are indicative of three independent experiments.
B–D, HEK293-TLR3 cells were cotransfected with pFA-IRF3 (30 ng) and pFR-regulated firefly luciferase (60 ng) (B), pFA-IRF7 (25 ng) and pFR-regulated firefly
luciferase (60 ng) (C), and IFN- promoter-regulated firefly luciferase (80 ng) and constitutively expressed TK Renilla luciferase (20 ng) (D) in the absence or
presence of Cactin (90 ng). Empty vector pcDNA3.1 (EV) was used to normalize the amount of total DNA transfected. Transfected cells were left overnight and
then treatedwith or without poly(I-C) (25g/ml) for 6 h. Cell lysates were assayed for firefly luciferase activity and normalized for transfection efficiency using
Renilla luciferase activity. Data are represented relative tountreated cells that hadbeen transfected in the absenceof hCactin. E, HEK293 cells, stably expressing
TLR3, were transfected with hCactin-specific siRNA or a sequence-scrambled version of this siRNA (25 nM) and grown for 48 h. Cells were stimulated with
poly(I-C) (25g/ml) for 0–6 h. Total cDNAwas generated and assayed by quantitative real-time PCR for levels of IFN-mRNA. The expression level of hCactin
was normalized relative to expression of the housekeeping gene HPRT. Data are presented relative to untreated cells transfectedwith scrambled siRNA. F and
G, U373 cells, stably transducedwith control or Cactin-specific shRNAwere stimulatedwith poly(I-C) (25g/ml) for 24 h. Supernatantswere analyzed for levels
of IFN- (F) and RANTES protein (G) by Mesoscale Singleplex and sandwich ELISA, respectively. H and I, HEK293-TLR3 cells were transfected with IRF3 (H) and
IRF7 (I) reporter constructs asdescribed forB andC. Cellswere then treatedwith LPS (100ng/ml) for 6handprocessedas above. J andK, HEK293-TLR4 cellswere
cotransfectedwith pFA-IRF3 (30 ng) (J) or pFA-IRF7 (25 ng) (K), pFR-regulated firefly luciferase (60 ng), and constitutively expressed TK Renilla luciferase (40 ng)
in theabsence (Mock) or presenceofCactin-specific siRNAor scrambled siRNA (25nM). 48hpost-transfection, cellswere treatedwithorwithout LPS (100ng/ml)
for 6 h. Cell lysates were assayed for firefly luciferase activity and normalized for transfection efficiency using Renilla luciferase activity. Data are presented
relative to unstimulated mock-transfected cells. All data are presented as the mean  S.E. (error bars) of triplicate determinations from three independent
experiments and analyzed by paired Student’s t test. *, p  0.05; **, p  0.01. B–D, H, and I, ligand-stimulated cells transfected with empty vector versus
ligand-stimulated cells transfected with hCactin.
FIGURE 5.hCactin positively regulates activationof c-Jun.A, HEK293-TLR4
cellswere cotransfectedwith pFA-Jun (30 ng), pFR-regulated firefly luciferase
(60ng), and constitutively expressed TKRenilla luciferase (20ng)with orwith-
out a construct encoding MEKK1 (30 ng) in the absence or presence of
hCactin (90 ng). Empty vector pcDNA3.1 (EV) was used to normalize the
amount of total DNA transfected. B, cells were similarly transfected with the
reporter constructs and MEKK1 in the absence or presence of Cactin-specific
siRNA or scrambled siRNA (25 nM). Transfected cells were left for 48 h, and cell
lysates were assayed for firefly luciferase activity and normalized for transfec-
tion efficiency using Renilla luciferase activity. Data are represented relative
to cells that had been transfected in the absence of MEKK1 and hCactin. Data
are presented as themean S.E. (error bars) of triplicate determinations from
three independent experiments and analyzed by paired Student’s t test. *,
p  0.05; **, p  0.01. A, cells transfected with MEKK1 and EV versus cells
transfected with MEKK1 and hCactin.
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inhibitory effects of hCactin on TLR signaling. Given that
Cactin was initially described in Drosophila as a protein-
binding partner for the IB ortholog Cactus, we investi-
gated the capacity of hCactin to interact with IB. Myc-
tagged hCactin was thus overexpressed in HEK293 cells and
subsequently immunoprecipitated, and immunoprecipitates
were probed for the presence of IB by Western immuno-
blotting (Fig. 6A). This approach failed to show association
of hCactin with IB. Cells were also stimulated with the
potent inflammatory stimulus IL-1 to examine if hCactin
could interact with IB under proinflammatory conditions.
Again there was no detectable association of hCactin with
IB (Fig. 6A). Using the same approach, we also explored
the potential of hCactin to associate with the other cytoplas-
mic IB proteins, namely IB and IB. However, there was
no detectable interaction with either of these proteins (data
not shown).
Bioinformatic analysis of hCactin using PROSITE, a pro-
tein family and domain data base, predicts two bipartite
nuclear localization sequences in the N-terminal region of
hCactin. We thus next investigated the ability of hCactin to
interact with IBL, a nuclear member of the IB family (31).
Myc-tagged hCactin and GFP-tagged IBL were co-ex-
pressed in HEK293 cells, and the two proteins were shown to
interact by co-immunoprecipitation analysis (Fig. 6B). This
interaction was apparent in the absence of any proinflamma-
tory stimulus and was not regulated by treatment of cells
with the inflammatory cytokine IL-1. In order to further con-
FIGURE 6.hCactin fails to interactwith IBbut interactswith nuclear IBL.A, HEK293 cellswere transfectedwithMyc-taggedhCactin (1g) or pcDNA3.1
(1 g) () and grown for 24 h. Cells were treated with or without IL-1 (10 ng/ml) for 15 min. Cell lysates (WCL) were immunoprecipitated (IP) using anti-Myc
antibodies. Immunoprecipitates and cell lysates were subsequently subjected to Western immunoblotting (IB) using anti-Myc and anti-IB antibodies.
B, HEK293 cells were cotransfected in the absence and presence of Myc-tagged hCactin (1 g) and GFP-tagged IBL (1 g) and grown for 24 h. Cells were
treatedwith or without IL-1 (10 ng/ml) for 15min. Cell lysates were immunoprecipitated using anti-Myc antibodies. Immunoprecipitates and cell lysates were
subsequently subjected to Western immunoblotting using anti-Myc and anti-GFP and anti--actin antibodies. C, HEK293 cells were grown in chamber slides
and transfected with and without hCactin-RFP (400 ng) (ii and iv) and GFP-tagged IBL (400 ng) (iii and iv) and grown for 24 h. Cells were harvested 24 h
post-transfection andmounted in anti-fademediumwithDAPI. Slideswere visualizedusing confocalmicroscopy. Confocal imageswere capturedusing a63
objective lens (oil immersion) on the UV Zeiss 510 Meta System laser-scanning microscope equipped with the appropriate filter sets. Data analysis was
performed using the LSM 5 browser imaging software. All data are representative of three independent experiments.
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firm the association of hCactin and IBL, hCactin was sub-
cloned into a red fluorescent protein (RFP) plasmid con-
struct, pIRES2-DsRed, and transfected into HEK293 cells
with or without IBL-GFP. DAPI was used in the mounting
medium to enable visualization of nuclei. hCactin showed a
strong nuclear localization with a speckled expression pat-
tern in some cells (Fig. 6C). Interestingly, IBL showed a very
similar nuclear expression pattern. This strongly suggests
nuclear co-localization of hCactin-RFP and IBL-GFP as
evidenced by the overlapping red and green formation of
yellow/orange immunofluorescence (Fig. 6C).
IBL Inhibits TLR-induced Activation of NF-B and IRFs—
Given the co-localization and interaction of hCactin and IBL,
the latter was next probed for its ability to regulate the TLR
signaling pathways that are sensitive to inhibition by hCactin.
Like hCactin, IBL was shown to negatively regulate LPS-in-
duced activation of NF-B (Fig. 7A)
and expression of TNF (Fig. 7B).
IBL also negatively affected the
IRF pathways as evidenced by its
inhibitory effects on LPS-induced
activation of IRF3 (Fig. 7C) and
IRF7 (Fig. 7D) and poly(I-C)-in-
duced activation of IRF3 (Fig. 7E)
and IRF7 (Fig. 7F). The magni-
tudes of the inhibitory effects of
IBL were comparable with those
shown by hCactin, and co-expres-
sion of both IBL and hCactin
failed to effect any additional inhi-
bition (data not shown), suggest-
ing that the two proteins may
manifest their regulatory effects
by the same mechanism.
The Nuclear Localization of
hCactin Is Critical for Manifesting
Its Inhibitory Effects on TLR Sig-
naling—The microscopy studies
described above clearly demon-
strate a nuclear subcellular local-
ization for hCactin. In order to
assess the importance of nuclear
localization for the inhibitory
effects of hCactin, a truncated
form of hCactin was cloned that
lacks both nuclear localization
sequences (depicted in Fig. 8A),
and its regulatory effects on TLR
signaling were compared with
those of full-length hCactin. It was
first necessary to confirm that the
truncated form of hCactin was
excluded from the nucleus. Con-
focal microscopic analysis of
HEK293 cells transfected with a
GFP-tagged form of truncated
hCactin revealed an exclusive
cytoplasmic localization for this
mutant (Fig. 8B). This mutant also offered an opportunity to
evaluate the importance of IBL binding for manifesting the
inhibitory effects of hCactin because co-immunoprecipita-
tion analysis demonstrates that truncated hCactin fails to
interact with IBL (Fig. 8C). Although the truncated form of
hCactin showed some modest inhibitory effects on activa-
tion of NF-B (Fig. 8D) and on LPS-induced (Fig. 8E) and
poly(I-C)-induced (Fig. 8, F and G) activation of IRFs, the
magnitudes of these effects are greatly reduced relative to
the inhibitory effects shown by full-length hCactin. These
findings provide strong evidence that the regulatory effects
of hCactin in innate immune signaling are heavily dependent
on its nuclear localization where it associates with a number
of proteins, including IBL. This study thus provides the first
functional characterization of hCactin and defines it as a
novel negative regulator of innate immune signaling.
FIGURE 7. IBL inhibits TLR-induced activation of NF-B and IRFs. A and B, HEK293 cells stably trans-
fected with TLR4 were cotransfected with plasmids encoding NF-B-regulated firefly luciferase (80 ng)
and constitutively expressed TK Renilla luciferase (40 ng) in the absence or presence of an expression
construct encoding IBL (90 ng). B, supernatants were analyzed for TNF production using sandwich ELISA.
HEK293-TLR4 (C and D) or HEK293-TLR3 cells (E and F) were cotransfected with pFA-IRF3 (30 ng) (C and E),
pFA-IRF7 (25 ng) (D and F), and pFR-regulated firefly luciferase (60 ng) and TK Renilla luciferase (20 ng) in
the absence or presence of IBL (90 ng). Empty vector pcDNA3.1 (EV) was used to normalize the amount
of total DNA transfected. Transfected cells were left overnight and then treated with or without LPS (100
ng/ml) (A–D) or poly(I-C) (25 g/ml) (E and F) for 6 h. Cell lysates were assayed for firefly luciferase activity
and normalized for transfection efficiency using Renilla luciferase activity. Data are presented relative to
untreated cells that had been transfected in the absence of IBL and represent themean S.E. (error bars)
of triplicate determinations from three independent experiments analyzed by paired Student’s t test. *,
p 0.05; **, p 0.01; ligand-stimulated cells transfected with empty vector versus ligand stimulated cells
transfected with IBL.
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The activation of NF-B and the subsequent induction of
immune response genes is a core defensemechanismof both fly
andmammalian innate immune responses. In addition, consid-
eration of the pathways leading to the activation of this ubiqui-
tous transcription factor reveals homology at the level of the
intracellular signaling components utilized, albeit not always of
precisely interchangeable function. Such a consideration of the
similarities or parallels between insect and mammalian innate
immunity highlights the significance of novel protein identifi-
cation in model organisms. In 2000, Lin et al. (23) identified
Cactin, a conserved protein that interacts withDrosophilaCac-
tus. Because themammalian homolog of cactus, IB, is central
in control of NF-B activation, the identification of a highly
conserved component with the potential to interact with and
possibly modify the function of this inhibitory protein was
exciting and inspired the presently described studies.
The Rel/NF-B pathway is essential in the early determina-
tion ofDrosophila embryonic dorsoventral polarity, andCactus
acts as a negative regulator of this pathway. Overexpression of
Cactin in a Cactus heterozygous background results in the
enhancement of the Cactus haploinsufficient phenotype,
strongly increasing both the embryonic lethality and the ven-
tralized phenotype observed. This suggests that Cactin in Dro-
sophilamay function in the dorsal-ventral pathway to positively
regulate the nuclear targeting ofDorsal. Given this regulation of
the NF-B in Drosophila, it seemed pertinent to initiate func-
tional characterization of hCactin with an analysis of its effect
on the NF-B pathway. Intriguingly, the present studies dem-
onstrate that hCactin acts as a negative regulator ofNF-B. The
evidence for this inhibitory role is especially compelling based
on the findings from a number of complementary approaches,
including overexpression studies and the suppression of endog-
enous expression of hCactin by two independent modalities,
namely siRNA- and shRNA-mediated suppression. Indeed, the
prolonged nature of NF-B in response to LPS and poly(I-C) in
cells where hCactin expression is suppressed suggests that
hCactin may be an endogenous braking system for NF-B acti-
vation by innate immune stimuli. hCactin appears to exert its
inhibitory influence on a wide array of inflammatory stimuli
that employ the NF-B pathway and in a cell type-independent
manner. Such inhibitory effects of hCactin contrast with the
proposed stimulatory effects of Cactin onDorsal inDrosophila.
Althoughhomology relationships are frequently exploited as an
aid in assignation of novel gene function, it is clear that homol-
ogy need not always correspond to conserved function (32).
Thus, Drosophila expresses genes encoding members of the
TRAF (TNF receptor-associated factor) family and homo-
logues of IKK and IKK/NEMO, and yet genetic studies have
failed so far to demonstrate involvement of any of these genes
downstream of Toll, unlike in mammalian Toll signaling.
Instead, genetic data point to the involvement of theDrosophila
equivalent of the mammalian signalosome comprising IKK-
and IKK-/NEMO homologues (33–35) in the Imd pathway. It
has therefore been observed that although homologues of the
human Toll signaling pathway exist in Drosophila, they need
not necessarily occupy an identical functional niche. Indeed, in
the present study, we show that the role of hCactin extends
beyond regulation of the NF-B pathway in that it also acts as a
strong inhibitor of IRF signaling and the induction of IRF-re-
sponsive genes, such as IFN.
In an effort to gain insight into the mechanistic basis of the
inhibitory effects of hCactin on NF-B, we initially assessed its
ability to interact with the cytoplasmic IB proteins based on
their homology to theCactin-interacting proteinCactus. There
was no detectable interaction of hCactin with any of the cyto-
plasmic IBs. However, hCactin associates with IBL, a nucle-
us-localized member of the IB family. This interaction with
IBL is likely to be of functional relevance because our findings
to date suggest that IBLmimics the regulatory effects of hCactin
on the NF-B and IRF pathways. The interaction of hCactin
with IBL is especially interesting given that the IBL gene is
encoded by the MHC Class III region of the human genome
(31), and an earlier study had reported hCactin as a binding
partner for other proteins that are encoded by this region of the
genome (36). The latter study had used a high throughput yeast
two-hybrid screen to document interaction partners for intra-
cellular proteins encoded by genes in theMHCClass III region
of the human genome, and hCactin was identified as an inter-
action partner for two of these proteins, namely RDRNA-bind-
ing protein (RDBP) (also called negative elongation factor sub-
unit E (NELF_E)) and leukocyte-specific transcript 1 protein
(LST1) (36). Intriguingly, the LST1 gene is located at a locus
that is only one gene removed from the TNF that in turn is only
one gene removed from the IKBL gene (31). The findings thus
propose a model where hCactin is capable of directly interact-
FIGURE 8. The nuclear localization of hCactin is important for manifesting its inhibitory effects on TLR signaling. A, schematic representation of
full-length and truncated hCactin with location of nuclear localization sequences (NLS) depicted. B, HEK293 cells were grown in chamber slides, transfected
withGFP-truncatedhCactin (800ng), andgrown for 24h. Cellswere harvested 24hpost-transfection andmounted in anti-fademediumwithDAPI. Slideswere
visualized using confocal microscopy. Confocal images were captured using a 40 objective lens (oil immersion) on the UV Zeiss 510 Meta System laser-
scanning microscope equipped with the appropriate filter sets. Data analysis was performed using the LSM 5 browser imaging software. i, DAPI staining
channel; ii, GFP channel; iii, overlay. C, HEK293-TLR4 cells were cotransfected with or without expression constructs encoding Myc-tagged truncated hCactin
(1 g) in the presence or absence of GFP-tagged IBL (1 g) and grown for 24 h. Cell lysates were immunoprecipitated (IP) with anti-Myc antibodies.
Immunoprecipitates and cell lysates were subsequently subjected to Western immunoblotting (IB) using anti-Myc, anti-GFP, and anti--actin antibodies.
Immunoreactivity was visualized using the Odyssey infrared imaging system. D, HEK293 cells stably transfected with TLR4 were cotransfected with plasmids
encoding NF-B-regulated firefly luciferase (80 ng) and constitutively expressed TK Renilla luciferase (40 ng) in the absence or presence of an expression
construct encoding full-length Cactin or truncated Cactin (T-Cactin) (0–90 ng). HEK293-TLR4 (E) or HEK293-TLR3 cells (F and G) were cotransfected with
pFA-IRF3 (30 ng) (E and F), pFA-IRF7 (25 ng) (G), and pFR-regulated firefly luciferase (60 ng) and TK Renilla luciferase (20 ng) in the absence or presence of
full-lengthCactinor truncatedCactin (0–90ng). Empty vectorpcDNA3.1wasused tonormalize theamountof totalDNA transfected. Transfected cellswere left
overnight and then treated with or without IL-1 (10 ng/ml) (D), LPS (100 ng/ml) (E), or poly(I-C) (25g/ml) (F and G) for 6 h. Cell lysates were assayed for firefly
luciferase activity and normalized for transfection efficiency using Renilla luciferase activity. Data are presented relative to untreated cells that had been
transfected in the absence of either Cactin construct and represent the mean S.E. (error bars) of triplicate determinations from three independent experi-
ments analyzedbypaired Student’s t test. *,p 0.05; **,p 0.01; ***,p 0.001; ligand-stimulated cells transfectedwith empty vector versus ligand stimulated
cells transfected with hCactin/truncated Cactin.
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ing with three proteins (LST1, RDBP, and IBL) that are
encoded by genes clustered in the MHC Class III region,
whereas it is also capable of functionally targeting TNF that is
also encoded by a gene in this cluster region. Thus, hCactinmay
emerge to be a key regulator of this genomic region and an
important modulator of disease states given that the MHC
Class III region contains immunity-related proteins that affect
susceptibility to numerous immunopathological disorders,
including rheumatoid arthritis. More specifically and relevant
to the present study, an earlier study aimed to identify non-
HLA genes in the chromosome 6p21.3 region that influence the
development of rheumatoid arthritis (37). This effort revealed
an HLA-independent susceptibility locus at the telomeric end
of the Class III region, which was eventually identified as a sin-
gle nucleotide polymorphism in the promoter/enhancer region
of the IBL gene that conferred transcriptional repression on
the promoter. Furthermore a single nucleotide polymorphism
giving rise to structural alteration at amino acid 224 in a pre-
dicted protein kinase C phosphorylation site of IBL defines a
propensity formore extensive and severe disease states in ulcer-
ative colitis (38). The interaction of hCactin with IBL in con-
junction with their similar functional properties in the present
study clearly implicates hCactin as a potential regulator of
immunity-mediated diseases previously associated with genes
that are encoded by theMHCClass III region of chromosome 6.
In addition to acting as regulators of the NF-B pathway, it is
also interesting to note that hCactin and IBL demonstrate
strong inhibitory effects on IRFs. Although the mechanism
underlying their inhibitory effects on NF-B is somewhat intu-
itive, given that IBL belongs to a family of proteins that inter-
act with and inhibit NF-B, the molecular basis of their modu-
lation of IRFs is less clear. The nuclear localization of hCactin
appears to be very important for its function, at least with
respect to regulation of NF-B and IRFs, because a truncation
mutant of hCactin that localizes to the cytoplasm fails to repli-
cate the inhibitory effects of nucleus-resident hCactin. The
design of this truncation mutant was dictated by the need to
remove the two nuclear localization motifs in the N-terminal
region but also by the mutant corresponding to that region of
DrosophilaCactin that strongly interacts with Cactus. Interest-
ingly, the truncation mutant fails to interact with IB, dem-
onstrating that the interaction of Drosophila Cactin with cyto-
plasmic Cactus is not conserved in humans.
It would appear that hCactin exemplifies the capacity of evo-
lution to diversify and functionally expand the core biological
processes embodied in a highly conserved protein. By exten-
sion, this may translate into multiple roles for hCactin in a
number of diseases. Indeed, although the potential role of
hCactin in inflammatory-based disorders has been discussed
above, it is worth emphasizing that hCactin was first observed
as a renal tumor antigen, NY-REN-24 (39), and is expressed in
multiplemyeloma (40). Thismay implicate a role for hCactin in
regulating cell transformation, and although such a function
remains speculative, it is interesting to note that hCactin nega-
tively regulates the prosurvival transcription factor NF-B.
However, the regulatory effects of hCactin clearly extend
beyond the NF-B pathway. More specifically, hCactin is con-
served across a broad phylogenetic range and is also found in
primitive organisms, such as C. elegans, in which there is no
NF-B/Rel homologue (41), and its TLR gene, TOL-1, fails to
play a direct role in defense against fungal or bacterial patho-
gens (41, 42). AlthoughC. elegans has apparently lost Rel-based
inducible defenses and is not dependent on a Toll pathway for
resistance to pathogenic challenge, it is clear that a homolog of
Cactin, displaying striking conservation, has been retained,
suggesting some additional targets for Cactin and a core biolog-
ical function for this protein. The process of evolution and spe-
ciation may have permitted the protein to adopt new functions
when encountering the increasingly complex biological sys-
tems and pathways of higher organisms. Although Cactin was
originally identified in the Toll dorsoventral regulatory path-
way inDrosophila, as a protein that regulates Dorsal transloca-
tion, it is now apparent that this function may have evolved in
higher organisms, and the present study strongly promotes
hCactin as an important regulator of innate immune signaling.
More importantly, it also targets a number of proteins, directly
or functionally, that are encoded by theMHCClass III region of
the genome and have been strongly associated with an array of
diseases. It is thus vitally important to gain an appreciation
of the physiological and pathological roles of hCactin. The pres-
ent study offers the first important step in this process.
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